Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Travis Redd

Concepts (186)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cornea
10
2025
156
3.040
Why?
Eye Infections, Bacterial
7
2025
46
2.500
Why?
Eye Infections, Fungal
6
2025
20
2.130
Why?
Corneal Diseases
4
2025
48
1.800
Why?
Ophthalmology
4
2022
122
1.730
Why?
Keratitis
3
2025
21
1.660
Why?
Artificial Intelligence
5
2025
389
1.480
Why?
Corneal Ulcer
5
2025
21
1.420
Why?
Refractive Surgical Procedures
2
2022
7
1.380
Why?
Diagnostic Techniques, Ophthalmological
3
2025
55
1.170
Why?
Keratoplasty, Penetrating
3
2025
9
1.090
Why?
Epithelium, Corneal
2
2025
41
1.080
Why?
Re-Epithelialization
1
2025
6
0.890
Why?
Descemet Membrane
1
2025
7
0.890
Why?
Trachoma
1
2024
2
0.860
Why?
Rosacea
2
2022
2
0.840
Why?
Diagnosis, Computer-Assisted
1
2024
92
0.800
Why?
Keratitis, Herpetic
1
2023
2
0.780
Why?
Retinopathy of Prematurity
3
2021
183
0.730
Why?
Herpes Simplex
1
2023
103
0.720
Why?
DNA, Fungal
1
2022
76
0.690
Why?
Metagenome
1
2022
127
0.660
Why?
DNA, Bacterial
1
2022
319
0.630
Why?
Myopia
1
2020
59
0.600
Why?
Bartonella Infections
1
2019
5
0.580
Why?
Glaucoma
1
2022
267
0.580
Why?
Retinal Artery Occlusion
1
2019
10
0.570
Why?
Electronic Health Records
3
2017
1210
0.550
Why?
Visual Acuity
6
2025
499
0.550
Why?
Fungi
3
2022
120
0.470
Why?
Meaningful Use
1
2015
13
0.460
Why?
ROC Curve
5
2024
617
0.450
Why?
Telemedicine
3
2021
966
0.440
Why?
Fluorescein Angiography
4
2022
197
0.430
Why?
Tomography, Optical Coherence
4
2022
283
0.400
Why?
Photography
3
2024
120
0.390
Why?
Health Plan Implementation
1
2014
143
0.390
Why?
Efficiency, Organizational
1
2014
144
0.390
Why?
Physicians, Primary Care
1
2015
210
0.380
Why?
Humans
37
2025
146342
0.350
Why?
Academic Medical Centers
1
2014
561
0.330
Why?
Blindness
2
2020
51
0.300
Why?
Ophthalmoscopy
2
2018
38
0.280
Why?
Bacteria
3
2024
766
0.260
Why?
Eyelids
2
2024
39
0.260
Why?
Conjunctivitis, Viral
2
2024
3
0.240
Why?
Ulcer
2
2024
37
0.240
Why?
Pediatrics
1
2014
1124
0.240
Why?
Sensitivity and Specificity
4
2024
1998
0.230
Why?
Prevalence
2
2024
2861
0.220
Why?
Anterior Eye Segment
1
2024
10
0.210
Why?
Male
20
2025
73396
0.210
Why?
Ethiopia
1
2024
43
0.210
Why?
Reproducibility of Results
5
2024
3416
0.210
Why?
Conjunctiva
1
2024
52
0.210
Why?
Cicatrix
2
2023
72
0.210
Why?
Area Under Curve
2
2021
335
0.200
Why?
Microscopy, Confocal
1
2024
322
0.190
Why?
Simplexvirus
1
2023
81
0.190
Why?
Keratoconjunctivitis
1
2023
11
0.190
Why?
Tetracycline
1
2022
11
0.190
Why?
Conjunctival Diseases
1
2023
23
0.190
Why?
Immunologic Deficiency Syndromes
1
2023
69
0.190
Why?
Infant, Newborn
4
2024
6460
0.190
Why?
Eyelid Diseases
1
2023
26
0.180
Why?
Cross-Sectional Studies
3
2024
5899
0.180
Why?
Child
6
2024
22693
0.180
Why?
Cat-Scratch Disease
1
2022
3
0.180
Why?
Technology
1
2022
100
0.180
Why?
Expert Systems
1
2021
4
0.180
Why?
Infant
3
2025
10114
0.170
Why?
Skin Diseases
1
2023
144
0.170
Why?
Parking Facilities
1
2021
1
0.170
Why?
Female
20
2025
79499
0.170
Why?
Point-of-Care Testing
1
2021
36
0.160
Why?
Imaging, Three-Dimensional
1
2024
582
0.160
Why?
Azithromycin
1
2021
101
0.160
Why?
Specialization
1
2021
137
0.160
Why?
Corneal Neovascularization
1
2020
15
0.160
Why?
Microsurgery
1
2020
75
0.160
Why?
Specimen Handling
1
2022
178
0.150
Why?
Algorithms
2
2025
1849
0.150
Why?
Education, Distance
1
2020
59
0.150
Why?
Eye Diseases
1
2021
100
0.150
Why?
Suture Techniques
1
2020
138
0.150
Why?
Mycoses
1
2020
87
0.150
Why?
Aged, 80 and over
6
2022
8391
0.150
Why?
Bartonella
1
2019
8
0.140
Why?
Antifungal Agents
1
2020
153
0.140
Why?
Chorioretinitis
1
2019
8
0.140
Why?
Retinitis
1
2019
21
0.140
Why?
Retina
1
2022
330
0.140
Why?
Blood Vessels
1
2020
164
0.140
Why?
Wound Healing
1
2021
354
0.140
Why?
Intraocular Pressure
1
2021
344
0.140
Why?
High-Throughput Nucleotide Sequencing
1
2022
539
0.140
Why?
Adult
13
2025
41087
0.140
Why?
Infant, Low Birth Weight
1
2018
154
0.130
Why?
Optic Nerve
1
2017
65
0.130
Why?
Diagnosis, Differential
1
2021
1503
0.130
Why?
Retinal Vessels
1
2017
79
0.120
Why?
Middle Aged
11
2025
36619
0.120
Why?
Practice Patterns, Physicians'
2
2017
1408
0.120
Why?
Uveitis
1
2017
152
0.120
Why?
Severity of Illness Index
2
2021
2921
0.110
Why?
Attitude to Computers
1
2015
28
0.110
Why?
Pediatricians
1
2017
120
0.110
Why?
Choroidal Neovascularization
1
2015
57
0.110
Why?
Angiotensin Receptor Antagonists
1
2015
115
0.110
Why?
Wet Macular Degeneration
1
2015
63
0.110
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2015
228
0.100
Why?
Child, Preschool
3
2024
11913
0.100
Why?
Adrenergic beta-Antagonists
1
2015
253
0.100
Why?
Anti-Bacterial Agents
2
2022
1942
0.100
Why?
Medicine
1
2015
127
0.100
Why?
Young Adult
5
2022
14330
0.100
Why?
Aged
7
2025
26432
0.100
Why?
Biomarkers
1
2024
4340
0.090
Why?
Pandemics
1
2021
1707
0.090
Why?
India
2
2024
213
0.090
Why?
Registries
1
2019
2400
0.080
Why?
Prospective Studies
4
2025
8123
0.080
Why?
Internship and Residency
1
2020
1281
0.080
Why?
Fundus Oculi
2
2020
89
0.070
Why?
Attitude of Health Personnel
1
2017
1219
0.070
Why?
Health Personnel
1
2014
754
0.070
Why?
Adolescent
3
2022
22557
0.060
Why?
Physicians
1
2015
955
0.060
Why?
Gestational Age
2
2021
990
0.060
Why?
Predictive Value of Tests
2
2021
2113
0.060
Why?
Corneal Topography
1
2024
25
0.050
Why?
Conjunctivitis, Bacterial
1
2024
12
0.050
Why?
Tomography
1
2024
44
0.050
Why?
Retrospective Studies
5
2022
17438
0.050
Why?
Real-Time Polymerase Chain Reaction
1
2024
334
0.050
Why?
Rubella virus
1
2023
7
0.050
Why?
Cyclosporine
1
2024
256
0.050
Why?
Hypesthesia
1
2023
21
0.050
Why?
Granuloma
1
2023
96
0.050
Why?
Tetracyclines
1
2022
16
0.050
Why?
Macrolides
1
2022
68
0.040
Why?
Slit Lamp Microscopy
1
2021
3
0.040
Why?
Acute Disease
1
2024
1038
0.040
Why?
False Positive Reactions
1
2021
124
0.040
Why?
Hospital Units
1
2021
32
0.040
Why?
Multimodal Imaging
1
2022
137
0.040
Why?
Sutures
1
2021
66
0.040
Why?
Corneal Perforation
1
2020
1
0.040
Why?
Natamycin
1
2020
2
0.040
Why?
United States
2
2017
16136
0.040
Why?
Injections, Intraocular
1
2020
14
0.040
Why?
Treatment Failure
1
2021
361
0.040
Why?
Corneal Stroma
1
2020
24
0.040
Why?
Symptom Assessment
1
2021
138
0.040
Why?
Voriconazole
1
2020
21
0.040
Why?
Glucocorticoids
1
2024
536
0.040
Why?
Immunosuppressive Agents
1
2024
829
0.040
Why?
Oregon
1
2019
83
0.040
Why?
Workflow
1
2021
182
0.040
Why?
Anti-Inflammatory Agents
1
2022
474
0.040
Why?
Administration, Oral
1
2021
872
0.030
Why?
Linear Models
1
2021
857
0.030
Why?
Triage
1
2021
243
0.030
Why?
Swine
1
2020
821
0.030
Why?
Infant, Very Low Birth Weight
1
2018
74
0.030
Why?
Outpatients
1
2021
440
0.030
Why?
Time Factors
2
2020
7109
0.030
Why?
Educational Measurement
1
2020
331
0.030
Why?
Clinical Decision-Making
1
2021
365
0.030
Why?
Observer Variation
1
2018
356
0.030
Why?
Physical Examination
1
2018
237
0.030
Why?
Medical History Taking
1
2017
117
0.030
Why?
Oxygen
1
2021
997
0.030
Why?
Double-Blind Method
1
2020
2070
0.030
Why?
Health Care Surveys
1
2017
541
0.030
Why?
Intensive Care Units, Neonatal
1
2018
295
0.030
Why?
Infant, Premature
1
2018
622
0.020
Why?
Odds Ratio
1
2015
1077
0.020
Why?
Incidence
1
2019
2936
0.020
Why?
Clinical Competence
1
2020
1272
0.020
Why?
Inflammation
1
2023
2919
0.020
Why?
Prognosis
1
2020
4351
0.020
Why?
Follow-Up Studies
1
2017
5439
0.020
Why?
Case-Control Studies
1
2015
3647
0.020
Why?
Risk Factors
1
2015
10921
0.010
Why?
Animals
1
2020
38107
0.010
Why?
Redd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)